Evidence map›Paper›PMID 22313019›Full record

ArticleLangmuir : the ACS journal of surfaces and colloids2012

Adsorption of doxorubicin on poly(methyl methacrylate)-chitosan-heparin-coated activated carbon beads.

Jianjun Miao, Fuming Zhang, Majde Takieddin, Shaker Mousa, Robert J Linhardt

Abstract read
In one paragraph

Article in Langmuir : the ACS journal of surfaces and colloids, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Jianjun MiaoDepartment of Chemical and Biological Engineering, Rensselaer Polytechnic Institute, Troy, New York 12180, United States.
Fuming Zhang
Majde Takieddin
Shaker Mousa
Robert J Linhardt

Funding

Development of Oral Small Molecule PCSK9 AntagonistR44HL137449 · NHLBI · SHIFA BIOMEDICAL CORPORATION · PI ELSHOURBAGY, NABIL A, MOUSA, SHAKER A · 2017 to 2018
$1.3M
Enabling high dose regional chemotherapy while minimizing systemic toxicityR41CA153973 · NCI · VASCULAR VISION PHARMACEUTICALS COMPANY · PI MOUSA, SHAKER A · 2010 to 2010
$159k
NCI NIH HHS 1R41CA153973-01NCI NIH HHS R41 CA153973NHLBI NIH HHS R44 HL137449
6 · The paper itself

Abstract

Extracorporeal filter cartridges, filled with an activated carbon bead (ACB) adsorbent, have been used for removal of overdosed cancer drugs from the blood. Coatings on adsorbent matrices, poly(methyl methacrylate) (PMMA)/activated carbon bead and PMMA/chitosan/heparin/ACB composites, were tested to improve their biocompatibility and blood compatibility. PMMA coating on ACBs was accomplished in a straightforward manner using a PMMA solution in ethyl acetate. A one-step hybrid coating of ACBs with PMMA-anticoagulant heparin required the use of acetone and water co-solvents. Multilayer coatings with three components, PMMA, chitosan, and heparin, involved three steps: PMMA was first coated on ACBs; chitosan was then coated on the PMMA-coated surface; and finally, heparin was covalently attached to the chitosan coating. Surface morphologies were studied by scanning electron microscopy. X-ray photoelectron spectroscopy confirmed the -SO(3)(-) group. Adsorption, of a chemotherapy drug (doxorubicin) from both water and phosphate-buffered saline, by the coated ACBs was examined. The adsorption isotherm curves were fitted using the Freundlich model. The current adsorption system might find potential applications in the removal of high-dose regional chemotherapy drugs while maintaining high efficiency, biocompatibility, and blood compatibility.

Indexed as

AdsorptionCharcoalChitosanDoxorubicinHeparinPhotoelectron SpectroscopyPolymethyl MethacrylateCharcoalChitosanDoxorubicinHeparinPolymethyl Methacrylate

Identifiers

PMID22313019
PMCPMC3309418

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.